Left Main Coronary Artery Revascularization Study is an individual patient data meta-analysis of 4,394 patients with significant left main disease and considered equally suitable for PCI or CABG, with a primary endpoint of 5-year all-cause mortality and with secondary endpoints of CV death, non-CV death, spontaneous MI, procedural MI, coronary revascularization, stroke.
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis
Main Results – PCI with Drug-Eluting Stents vs. CABG in Left Main Coronary Artery Disease. An Individual Patient Data Meta-Analysis (Sabatine, AHA 2021)
Risk Prediction with the Anatomic SYNTAX Score in Patients with Left Main Coronary Artery Disease Undergoing PCI or CABG (Bergmark, AHA 2022)
PCI versus CABG for left main disease in patients with versus without acute coronary syndromes – A pooled analysis (Gaba, TCT 2023)
PCI vs CABG in Patients with Left Main Coronary Artery Disease with or without Diabetes Mellitus – A Pooled Analysis of Four Randomized Clinical Trials (Gaba, CRT 2023)
Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials. JAMA Cardiol. 2023 Jul 1;8(7):631-639.